-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, SXvo1jXAnFo4kC5dJ8V39v4nbeKsc6CvKznIRFweX9sSNwJYi6sGEKPn1eWo7C5w 8HDCDYD4PK+MiYAdHBOrTw== 0000950103-99-000619.txt : 19990707 0000950103-99-000619.hdr.sgml : 19990707 ACCESSION NUMBER: 0000950103-99-000619 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19990706 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: IMCLONE SYSTEMS INC/DE CENTRAL INDEX KEY: 0000765258 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 042834797 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: SEC FILE NUMBER: 005-42743 FILM NUMBER: 99659390 BUSINESS ADDRESS: STREET 1: 180 VARICK ST CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: 2126451405 MAIL ADDRESS: STREET 1: 180 VARICK ST CITY: NEW YORK STATE: NY ZIP: 10014 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: WAKSAL SAMUEL D DR CENTRAL INDEX KEY: 0000936749 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 180 VARICK STREET CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: 2126451405 MAIL ADDRESS: STREET 1: 180 VARICK STREET CITY: NEW YORK STATE: NY ZIP: 10014 SC 13D/A 1 FINAL AMENDMENT =============================================================================== UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ----------------------- SCHEDULE 13D Under the Securities Exchange Act of 1934 (Final Amendment) IMCLONE SYSTEMS INCORPORATED (Name of Issuer) COMMON STOCK $.001 PAR VALUE (Title of Class of Securities) ----------------------- 452 45W 109 (Cusip Number) DR. SAMUEL D. WAKSAL (Name of Persons Filing Statement) JOHN B. LANDES VICE PRESIDENT, BUSINESS DEVELOPMENT AND GENERAL COUNSEL IMCLONE SYSTEMS INCORPORATED 180 Varick Street New York, New York 10014 Tel No.: (212) 645-1405 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) May 7, 1999 (Date of Event which Requires Filing of this Statement) ----------------------- If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this statement because of Rule 13d-1(b)(3) or (4), check the following: [ ] =============================================================================== This Amendment is the final amendment to the Schedule 13D dated June 4, 1996 (the "Schedule 13D") filed by Dr. Samuel D. Waksal ("Dr. Waksal") with respect to the Common Stock, $.001 par value per share (the "Common Stock"), of ImClone Systems Incorporated, a Delaware corporation (the "Issuer"), and is being filed to report that Dr. Waksal has ceased to be the beneficial owner of more than five percent of the Common Stock and that his reporting obligation pursuant to Section 13(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and the rules and regulations promulgated thereunder is therefore terminated. Unless otherwise indicated, each capitalized term used but not defined herein shall have the meaning assigned to such term in the Schedule 13D. Item 5. Interest in Securities of the Issuer. The response set forth in Item 5 of the Schedule 13D is hereby amended by adding the following: On May 7, 1999, Dr. Waksal ceased to be the beneficial owner of more than 5% of shares of Common Stock. Dr. Waksal's reporting obligation pursuant to Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder is therefore terminated. 1 SIGNATURES After reasonable inquiry and to the best knowledge and belief of the undersigned, the undersigned certifies that the information set forth in this statement is true, complete and correct. Date: June 30, 1999 /s/ Samuel D. Waksal --------------------------------------------- Name: Dr. Samuel D. Waksal Title: President and Chief Operating Officer 2 -----END PRIVACY-ENHANCED MESSAGE-----